Joshua Bonney 高级律师, Public Finance, Infrastructure
Washington, D.C.
Washington, D.C.
Washington, D.C.
Joshua has closed over 150 financing transactions aggregating tens of billions for state and local government capital programs, nonprofit capital projects, energy production and transmission facilities, airport systems, healthcare systems, surface transportation systems, water systems and affordable multifamily rental housing projects, among others. He regularly serves as bond counsel, underwriter’s counsel, disclosure counsel, and borrower’s counsel and has experience with all the major financing products available in the market. His expertise includes tax-exempt and taxable financings, commercial paper, credit and liquidity-enhanced transactions, fixed, variable, and multi-modal debt, senior and subordinate structures, as well as tenders, exchanges, conversions and reofferings. Joshua also works closely with our Band 1-ranked (Chambers USA) infrastructure group and is experienced in alternative delivery and public-private partnership (P3) transactions across various segments of the infrastructure sector.
Washington, D.C.
Washington, D.C.
Joshua has closed over 150 financing transactions aggregating tens of billions for state and local government capital programs, nonprofit capital projects, energy production and transmission facilities, airport systems, healthcare systems, surface transportation systems, water systems and affordable multifamily rental housing projects, among others. He regularly serves as bond counsel, underwriter’s counsel, disclosure counsel, and borrower’s counsel and has experience with all the major financing products available in the market. His expertise includes tax-exempt and taxable financings, commercial paper, credit and liquidity-enhanced transactions, fixed, variable, and multi-modal debt, senior and subordinate structures, as well as tenders, exchanges, conversions and reofferings. Joshua also works closely with our Band 1-ranked (Chambers USA) infrastructure group and is experienced in alternative delivery and public-private partnership (P3) transactions across various segments of the infrastructure sector.
东京
He also has extensive experience in fund formation, real estate and various types of finance transactions.
Hiroki has a deep understanding of clients’ needs from his secondment experience with a U.S. investment bank in 2005 and a Japanese major trading house from 2012 to 2014.
Prior to joining Orrick, Hiroki worked at O’Melveny’s Tokyo office as a counsel where he mainly worked on cross border M&A.
东京
He also has extensive experience in fund formation, real estate and various types of finance transactions.
Hiroki has a deep understanding of clients’ needs from his secondment experience with a U.S. investment bank in 2005 and a Japanese major trading house from 2012 to 2014.
Prior to joining Orrick, Hiroki worked at O’Melveny’s Tokyo office as a counsel where he mainly worked on cross border M&A.
New York
Christine has litigated a wide range of subject matters relating to drug development, including humanized antibody technology, recombinant DNA vectors, nextgen DNA sequencing, complex chemistry and drugs for the treatment of cancer, HIV, diabetes, multiple sclerosis, depression and anxiety, immune disorders, and dermatologic conditions. Christine is experienced in other industries as well, including medical devices, semiconductors, telecommunications and electronics.
Christine’s recent successes include obtaining a trial win and injunction for a major pharmaceutical company’s blockbuster cancer drug, securing a consent judgment and recommendation for fees for two innovator companies’ treatment relating to rare cancers, and representing a biotech company in Patent Office proceedings against a major pharmaceutical company, securing a settlement of $1.25 billion.
New York
Christine has litigated a wide range of subject matters relating to drug development, including humanized antibody technology, recombinant DNA vectors, nextgen DNA sequencing, complex chemistry and drugs for the treatment of cancer, HIV, diabetes, multiple sclerosis, depression and anxiety, immune disorders, and dermatologic conditions. Christine is experienced in other industries as well, including medical devices, semiconductors, telecommunications and electronics.
Christine’s recent successes include obtaining a trial win and injunction for a major pharmaceutical company’s blockbuster cancer drug, securing a consent judgment and recommendation for fees for two innovator companies’ treatment relating to rare cancers, and representing a biotech company in Patent Office proceedings against a major pharmaceutical company, securing a settlement of $1.25 billion.
Austin
Zac advises clients on:
As co-lead of the firm’s Energy Tech Team, Zac focuses on supporting companies and investors developing technologies like hyperscale data centers, alternative fuels, carbon capture, eVTOL aircraft, agtech and digital infrastructure. Zac is a key member of Orrick's energy transition practice, which was recognized as Band 1 in Energy Transition by Chambers USA (2023).
Zac is passionate about legal tech and implementing AI tools to enhance legal services. He helps lead the firm’s MAPE 2.0 project team, a platform that transforms M&A execution, which won the Financial Times' Reinventing the Legal Practice category.
Austin
Zac advises clients on:
As co-lead of the firm’s Energy Tech Team, Zac focuses on supporting companies and investors developing technologies like hyperscale data centers, alternative fuels, carbon capture, eVTOL aircraft, agtech and digital infrastructure. Zac is a key member of Orrick's energy transition practice, which was recognized as Band 1 in Energy Transition by Chambers USA (2023).
Zac is passionate about legal tech and implementing AI tools to enhance legal services. He helps lead the firm’s MAPE 2.0 project team, a platform that transforms M&A execution, which won the Financial Times' Reinventing the Legal Practice category.
New York
Max has extensive experience in a broad range of domestic and cross-border corporate and transactional matters, including venture capital and growth equity financings, mergers & acquisitions, fund formation and SPAC transactions. He has represented both early and growth stage companies in hundreds of venture capital financings, growth equity investments and M&A transactions, and he regularly advises leading venture capital and private equity funds on their investments across the innovation ecosystem.
Max is also known for working closely with clients to provide strategic business insights and outside general counsel services, advising clients on corporate governance and boardroom matters, product development and design, fundraising strategy and general commercial matters.
In addition to representing US companies on domestic transactions, Max has substantial experience representing clients outside the US, including emerging companies and venture funds operating in Canada, Europe, Latin America, India, Japan, Singapore, China, Australia, Israel, the Cayman Islands and various other jurisdictions.
New York
Max has extensive experience in a broad range of domestic and cross-border corporate and transactional matters, including venture capital and growth equity financings, mergers & acquisitions, fund formation and SPAC transactions. He has represented both early and growth stage companies in hundreds of venture capital financings, growth equity investments and M&A transactions, and he regularly advises leading venture capital and private equity funds on their investments across the innovation ecosystem.
Max is also known for working closely with clients to provide strategic business insights and outside general counsel services, advising clients on corporate governance and boardroom matters, product development and design, fundraising strategy and general commercial matters.
In addition to representing US companies on domestic transactions, Max has substantial experience representing clients outside the US, including emerging companies and venture funds operating in Canada, Europe, Latin America, India, Japan, Singapore, China, Australia, Israel, the Cayman Islands and various other jurisdictions.
旧金山
Smith律师曾处理超过400宗并购交易,并为客户就涉及上市公司和私人公司的各类并购交易提供法律服务,包括协议兼并、拍卖出价程序、跨国交易、出售不良资产(包括363条款下的出售交易)、杠杆收购、要约收购、要约互换、私有化、对等合并交易、退市交易、敌意收购、代理权争夺、反收购以及对公司部门和子公司的买卖等。
Smith律师曾代表客户处理涉及美国证监会注册登记、承销及私募股票和债券发行等交易,并协助公司处理有关发行人的股权和债务要约收购、资本调整、重组和供股等事务。他经常代表客户编制和储存定期向美国证监会提交的报告、股东委托书及威廉姆斯法案(Williams Act)报告。另外,他还协助客户处理有关合规事宜,包括在2010年通过的多德-弗兰克法案(Dodd-Frank Act)和在2002年通过的萨班斯法案(Sarbanes-Oxley)的合规事宜、1934年证券交易法案第16条、实时披露规定合规、出售限制性证券和内幕人士出售的证券、有关10b-5规定和FD法规的披露事宜以及纳斯达克和纽约证券交易所的合规和调查等方面的业务。
Smith律师对在特拉华州和加州的企业、合伙公司和有限责任公司的法律均有丰富的经验。他经常就公司治理、股东争取权益行动、合规事务、内部调查、诚信义务、行政人员薪酬、股东提案、赔偿、董事和职员的保险和股东间的协议等事宜为董事会、股东、审计、薪酬及人员任命委员会、管理委员会提供法律服务。
Smith律师还在并购、证券和公司法律事务方面提供专家意见证言。
沙加缅度; 旧金山
In doing so, Julie closely collaborates with each client, gathering an in-depth understanding of their specific tensions, challenges and objectives. Legal 500 noted she “truly understands corporate politics and works with in-house counsel to understand the intersections of legal advice and business objectives.” Julie then draws upon nearly three decades of experience to guide clients towards the best possible resolution. Her client-focused approach is one of many reasons she was selected to lead Orrick’s global employment practice, which Chambers ranks as one of the country’s foremost practices and describes Julie as “a big thinker and a thought leader.”
Julie has experience defending both class actions and individual plaintiff cases. She has successfully defended clients in trial and arbitration and helps clients with all types of employment matters, including complex wage-and-hour class, collective and representative actions; pay equity and promotion cases; whistleblower retaliation actions, discrimination, harassment and retaliation litigation and trade secret and non-compete matters. She also guides clients through systemic government investigations and audits. Julie is proactive in helping clients avoid litigation by assisting them with the development of policies and practices designed to minimize exposure, including advice and counselling work in the areas of AI and DEI in selection and recruiting.
Julie is honored to be a Fellow of the College of Labor and Employment and a member of the American Employment Law Council. She also served as a Council Member of the American Bar Association Labor and Employment Law Section.